Chemical Compound

Lopinavir Metabolite M-1

CAS Registry Number 192725-39-6
Back to search Request a Quote
Lopinavir Metabolite M-1 chemical structure
Primary Record

Lopinavir Metabolite M-1

In stock
6,458 g
Purity
98.5 %
CAS
192725-39-6

Compound Identifiers & Properties

CAS
192725-39-6
PubChem CID
486506
SMILES
CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCC(=O)NC4=O)O
Canonical SMILES
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCC(=O)NC1=O

Names & Synonyms

  • Lopinavir Metabolite M-1
  • 4-Oxolopinavir
  • 4-Oxo-lopinavir
  • Lopinavir (m1)
  • Lopinavir Metabolite M1
  • FA4KE7HY7K
  • UNII-FA4KE7HY7K
  • Lopinavir M1 metabolite
  • AC1LAED8
  • CHEMBL30185
  • Lopinavir impurity E [WHO-IP]
  • 192725-39-6
  • orb1984684
  • AIDS211894
  • GLXC-15404
  • BDBM50099842
  • CID486506
  • ZINC28766363
  • AKOS040757133
  • HY-136703
  • CS-0133380
  • (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-2-(2,4-dioxo-1,3-diazinan-1-yl)-3-methylbutanamide
  • J1.169.279F
  • DES(2-oxo-tetrahydropyrimidinyl)-2,4-dioxo-tetrahydropyrimidinyllopinavir
  • 1(2H)-Pyrimidineacetamide, N-((1S,3S,4S)-4-((2-(2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2,4-dioxo-, (alphaS)-
  • (|AS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|A-(1-methylethyl)-2,4-dioxo-1(2H)-pyrimidineacetami-de
  • (2S)-N-[(1S,3S,4S)-1-Benzyl-3-hydroxy-4-(2,6-dimethylphenoxyacetylamino)-5-phenylpentyl]-2-(2,4-dioxohexahydropyrimidine-1-yl)-3-methylbutanamide
  • (2S)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-pentyl]-2-(2,4-dioxohexahydropyrimidin-1-yl)-3-methyl-butanamide
  • (2S)-N-[(2S,4S,5S)-5-[2-(2,6-DIMETHYLPHENOXY)ACETAMIDO]-4-HYDROXY-1,6-DIPHENYLHEXAN-2-YL]-2-(2,4-DIOXO-1,3-DIAZINAN-1-YL)-3-METHYLBUTANAMIDE
  • (alphaS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2,4-dioxo-1(2H)-pyrimidineacetami- de
  • (As)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)Acetyl]Amino]-3-Hydroxy-5-Phenyl-1-(Phenylmethyl)Pentyl]Tetrahydro-A-(1-methylethyl)-2,4-Dioxo-1(2H)-Pyrimidineacetamide
  • (S)-N-[(S)-4-[2-(2,6-Dimethyl-phenoxy)-acetylamino]-3-(S)-hydroxy-5-phenyl-1-((S)-phenylmethyl)-pentyl]-2-(2,4-dioxo-tetrahydro-pyrimidin-1-yl)-3-methyl-butyramide
  • (S)-N-{(1S,3S,4S)-1-Benzyl-4-[2-(2,6-dimethyl-phenoxy)-ethanoylamino]-3-hydroxy-5-phenyl-pentyl}-2-(2,4-dioxo-tetrahydro-pyrimidin-1-yl)-3-methyl-butyramide
  • 1(2H)-PYRIMIDINEACETAMIDE, N-((1S,3S,4S)-4-((2-(2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-.ALPHA.-(1-METHYLETHYL)-2,4-DIOXO-, (.ALPHA.S)-
  • M-1
  • N-[(1S,2S,4S)-4-[[(S)-2-[Hexahydro-2,4-dioxopyrimidine-1-yl]-3-methylbutyryl]amino]-2-hydroxy-1,4-dibenzylbutyl]-2-(2,6-dimethylphenoxy)acetamide
  • N-[(3S,5S)-4-[2-(2,6-Dimethyl-phenoxy)-acetylamino]-3-hydroxy-5-phenyl-1-((S)-phenylmethyl)-pentyl]-2-(2,4-dioxo-tetrahydro-pyrimidin-1-yl)-3-(S)-methyl-butyramide